HomeBusinessSuraksha Diagnostic IPO: Everything You Need to Know

Suraksha Diagnostic IPO: Everything You Need to Know

The Suraksha Diagnostic IPO has officially opened for subscription, giving investors a chance to own a piece of this growing healthcare company. The IPO will remain open for bidding until December 3, and its shares are expected to be listed on the Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) on December 6.

Key Details About Suraksha Diagnostic IPO

Key Details About Suraksha Diagnostic IPO

IPO Size and Fundraising

Suraksha Diagnostic Limited plans to raise ₹846.25 crore through its IPO. However, it is important to note that:

  • The entire issue consists of an Offer for Sale (OFS).
  • Existing investors will sell 19,189,330 shares worth ₹846.25 crore.
  • No new shares will be issued by the company.

Price Band and Lot Size

The company has set the IPO price band at ₹420 to ₹441 per share. Here’s how much you can invest:

  • Minimum Investment:
    1. Retail investors can bid for 1 lot, which includes 34 shares.
    2. At the upper price band of ₹441, the minimum investment would be ₹14,994.
  • Maximum Investment:
    1. Retail investors can apply for up to 13 lots, which totals 442 shares.
    2. The maximum investment at the upper price band would be ₹194,922.

IPO Reservation Details

Suraksha Diagnostic has allocated shares for different categories of investors:

  • 50% for Qualified Institutional Buyers (QIBs).
  • 35% for Retail Investors.
  • 15% for Non-Institutional Investors (NIIs).

This allocation ensures that retail investors have a fair opportunity to participate in the IPO.

About Suraksha Diagnostic Limited

About Suraksha Diagnostic Limited

1. Company Overview

Founded in 2005, Suraksha Diagnostic is a leading healthcare company offering a wide range of diagnostic and medical services. The company’s services include:

  • Radiology testing.
  • Medical consultancy.
  • Pathology services.

2. Extensive Network

  • 44 diagnostic centers and 120 polyclinics across various locations.
  • A network of over 750 doctors providing expert consultations.
  • 8 laboratories and a central reference lab.
  • 215 customer touchpoints for convenient access to services.

3. Comprehensive Services

Suraksha Diagnostic provides both online and offline consultation services, making it easier for patients to get medical advice and testing under one roof.

Why Invest in Suraksha Diagnostic IPO?

Established Market Presence – With a strong network of diagnostic centers and polyclinics, Suraksha Diagnostics has built a solid reputation in the healthcare sector.

Expanding Healthcare Demand – The demand for diagnostic and healthcare services is rising, especially post-pandemic, making this sector attractive for investors.

Balanced Financial Structure – The company is growing steadily, with a strong focus on expanding its service reach and maintaining profitability.

Things to Consider Before Investing

While investing in an IPO can be exciting, it’s important to evaluate your decision carefully:

  • Entirely OFS Issue: Since the IPO is only an Offer for Sale, the proceeds will go to existing shareholders, not the company.
  • Risk in the Healthcare Sector: Like any business, diagnostic services face competition, and regulations in healthcare can impact operations.
  • Investors’ Objective: Ensure your investment aligns with your financial goals and risk appetite.

How to Apply for Suraksha Diagnostic IPO

You can apply for the IPO through your demat account via online platforms like:

  • Zerodha
  • Upstox
  • Groww

Alternatively, you can apply offline by filling out a physical application form through your broker or bank.

Conclusion

The Suraksha Diagnostic Limited IPO offers a promising opportunity for investors looking to tap into the growing healthcare market. With its extensive network, diversified services, and increasing demand for diagnostics, the company is well-positioned for growth. However, as with any investment, do your research and consider your financial goals before applying.

LATEST POST